XML 53 R38.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements - Additional Information (Detail) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Apr. 30, 2020
Oct. 30, 2021
Oct. 31, 2020
Oct. 30, 2021
Oct. 31, 2020
Fair Value Measurements Disclosure [Line Items]          
Repayment of outstanding borrowings         $ 330,000,000
Asset impairment charges   $ 0 $ 0 $ 0 153,617,000 [1]
Impairment of operating lease ROU assets   0 0 0 84,100,000
Retail Stores          
Fair Value Measurements Disclosure [Line Items]          
Asset impairment charges         109,600,000
Impairment of operating lease ROU assets         84,100,000
Impairment of certain cost and equity method investments         18,000,000.0
Fair value of impaired asset     $ 163,400,000   163,400,000
Store Property and Equipment (Fixtures and Equipment and Leasehold Improvements) | Retail Stores          
Fair Value Measurements Disclosure [Line Items]          
Asset impairment charges         25,500,000
Corporate Property and Equipment | Retail Stores          
Fair Value Measurements Disclosure [Line Items]          
Asset impairment charges         26,000,000.0
Convertible Senior Notes Due 2025          
Fair Value Measurements Disclosure [Line Items]          
Aggregate principal amount of debt issued $ 415,000,000        
Debt instrument, maturity year 2025        
Revolving Credit Facility          
Fair Value Measurements Disclosure [Line Items]          
Outstanding borrowings   $ 0   $ 0  
Repayment of outstanding borrowings         $ 330,000,000
[1] During the 39 weeks ended October 31, 2020, the Company recorded asset impairment charges of $153.6 million.  Included in this amount are retail store impairment charges of $109.6 million, of which $84.1 million relates to operating lease ROU assets and $25.5 million relates to store property and equipment (fixtures and equipment and leasehold improvements).  We also recorded $26.0 million of impairment related charges to certain corporate property and equipment, as well as $18.0 million of impairment charges related to certain cost and equity method investments.